Cargando…

Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”

Background: Apocynin (APO) is a bioactive phytochemical with prominent anti-inflammatory and anti-oxidant activities. Designing a nano-delivery system targeted to potentiate the gastric antiulcerogenic activity of APO has not been investigated yet. Chitosan oligosaccharide (COS) is a low molecular w...

Descripción completa

Detalles Bibliográficos
Autores principales: Anter, Hend Mohamed, Abu Hashim, Irhan Ibrahim, Awadin, Walaa, Meshali, Mahasen Mohamed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620830/
https://www.ncbi.nlm.nih.gov/pubmed/31456637
http://dx.doi.org/10.2147/IJN.S209987
_version_ 1783434105386434560
author Anter, Hend Mohamed
Abu Hashim, Irhan Ibrahim
Awadin, Walaa
Meshali, Mahasen Mohamed
author_facet Anter, Hend Mohamed
Abu Hashim, Irhan Ibrahim
Awadin, Walaa
Meshali, Mahasen Mohamed
author_sort Anter, Hend Mohamed
collection PubMed
description Background: Apocynin (APO) is a bioactive phytochemical with prominent anti-inflammatory and anti-oxidant activities. Designing a nano-delivery system targeted to potentiate the gastric antiulcerogenic activity of APO has not been investigated yet. Chitosan oligosaccharide (COS) is a low molecular weight chitosan and its oral nanoparticulate system for potentiating the antiulcerogenic activity of the loaded APO has been described here. Methods: COS-nanoparticles (NP(s)) loaded with APO (using tripolyphosphate [TPP] as a cross-linker) were prepared by ionic gelation method and fully characterized. The chosen formula was extensively evaluated regarding in vitro release profile, kinetic analysis, and stability at refrigerated and room temperatures. Ultimately, the in vivo antiulcerogenic activity against ketoprofen (KP)-induced gastric ulceration in rats was assessed by macroscopic parameters including Paul’s index and antiulcerogenic activity, histopathological examination, immunohistochemical (IHC) evaluation of cyclooxygenase-2 (COX-2) expression level in ulcerated gastric tissue, and biochemical measurement of oxidative stress markers and nitric oxide (NO) levels. Results: The selected NP(s) formula with COS (0.5 % w/v) and TPP (0.1% w/v) was the most appropriate one with drug entrapment efficiency percentage of 35.06%, particle size of 436.20 nm, zeta potential of +38.20 mV, and mucoadhesive strength of 51.22%. It exhibited a biphasic in vitro release pattern as well as high stability at refrigerated temperature for a 6-month storage period. APO-loaded COS-NP(s) provoked marvelous antiulcerogenic activity against KP-induced gastric ulceration in rats compared with free APO treated group, which was emphasized by histopathological, IHC, and biochemical studies. Conclusion: In conclusion, APO-loaded COS-NP(s) could be considered as a promising oral phytopharmaceutical nanoparticulate system for management of gastric ulceration.
format Online
Article
Text
id pubmed-6620830
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-66208302019-08-27 Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin” Anter, Hend Mohamed Abu Hashim, Irhan Ibrahim Awadin, Walaa Meshali, Mahasen Mohamed Int J Nanomedicine Original Research Background: Apocynin (APO) is a bioactive phytochemical with prominent anti-inflammatory and anti-oxidant activities. Designing a nano-delivery system targeted to potentiate the gastric antiulcerogenic activity of APO has not been investigated yet. Chitosan oligosaccharide (COS) is a low molecular weight chitosan and its oral nanoparticulate system for potentiating the antiulcerogenic activity of the loaded APO has been described here. Methods: COS-nanoparticles (NP(s)) loaded with APO (using tripolyphosphate [TPP] as a cross-linker) were prepared by ionic gelation method and fully characterized. The chosen formula was extensively evaluated regarding in vitro release profile, kinetic analysis, and stability at refrigerated and room temperatures. Ultimately, the in vivo antiulcerogenic activity against ketoprofen (KP)-induced gastric ulceration in rats was assessed by macroscopic parameters including Paul’s index and antiulcerogenic activity, histopathological examination, immunohistochemical (IHC) evaluation of cyclooxygenase-2 (COX-2) expression level in ulcerated gastric tissue, and biochemical measurement of oxidative stress markers and nitric oxide (NO) levels. Results: The selected NP(s) formula with COS (0.5 % w/v) and TPP (0.1% w/v) was the most appropriate one with drug entrapment efficiency percentage of 35.06%, particle size of 436.20 nm, zeta potential of +38.20 mV, and mucoadhesive strength of 51.22%. It exhibited a biphasic in vitro release pattern as well as high stability at refrigerated temperature for a 6-month storage period. APO-loaded COS-NP(s) provoked marvelous antiulcerogenic activity against KP-induced gastric ulceration in rats compared with free APO treated group, which was emphasized by histopathological, IHC, and biochemical studies. Conclusion: In conclusion, APO-loaded COS-NP(s) could be considered as a promising oral phytopharmaceutical nanoparticulate system for management of gastric ulceration. Dove 2019-07-05 /pmc/articles/PMC6620830/ /pubmed/31456637 http://dx.doi.org/10.2147/IJN.S209987 Text en © 2019 Anter et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Anter, Hend Mohamed
Abu Hashim, Irhan Ibrahim
Awadin, Walaa
Meshali, Mahasen Mohamed
Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
title Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
title_full Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
title_fullStr Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
title_full_unstemmed Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
title_short Novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
title_sort novel chitosan oligosaccharide-based nanoparticles for gastric mucosal administration of the phytochemical “apocynin”
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620830/
https://www.ncbi.nlm.nih.gov/pubmed/31456637
http://dx.doi.org/10.2147/IJN.S209987
work_keys_str_mv AT anterhendmohamed novelchitosanoligosaccharidebasednanoparticlesforgastricmucosaladministrationofthephytochemicalapocynin
AT abuhashimirhanibrahim novelchitosanoligosaccharidebasednanoparticlesforgastricmucosaladministrationofthephytochemicalapocynin
AT awadinwalaa novelchitosanoligosaccharidebasednanoparticlesforgastricmucosaladministrationofthephytochemicalapocynin
AT meshalimahasenmohamed novelchitosanoligosaccharidebasednanoparticlesforgastricmucosaladministrationofthephytochemicalapocynin